PTPN11 and neoplasm: SH3809 (87) is a small molecule allosteric inhibitor targeting SHP2 developed by Nanjing Sanhome Pharmaceutical Co Ltd. In vitro enzyme activity inhibition assays and cell viability inhibition assays have demonstrated that SH3809 inhibits SHP-2 enzyme activity and inhibits tumor growth.